全文获取类型
收费全文 | 1391273篇 |
免费 | 91232篇 |
国内免费 | 3426篇 |
专业分类
耳鼻咽喉 | 16657篇 |
儿科学 | 46662篇 |
妇产科学 | 35784篇 |
基础医学 | 191783篇 |
口腔科学 | 33282篇 |
临床医学 | 124032篇 |
内科学 | 269494篇 |
皮肤病学 | 26586篇 |
神经病学 | 117192篇 |
特种医学 | 56514篇 |
外国民族医学 | 318篇 |
外科学 | 213921篇 |
综合类 | 28691篇 |
现状与发展 | 1篇 |
一般理论 | 553篇 |
预防医学 | 110758篇 |
眼科学 | 30346篇 |
药学 | 95921篇 |
4篇 | |
中国医学 | 2944篇 |
肿瘤学 | 84488篇 |
出版年
2021年 | 11571篇 |
2019年 | 11814篇 |
2018年 | 37951篇 |
2017年 | 29755篇 |
2016年 | 34224篇 |
2015年 | 16591篇 |
2014年 | 22623篇 |
2013年 | 32901篇 |
2012年 | 51091篇 |
2011年 | 67854篇 |
2010年 | 46007篇 |
2009年 | 37404篇 |
2008年 | 63347篇 |
2007年 | 69162篇 |
2006年 | 46103篇 |
2005年 | 46882篇 |
2004年 | 46776篇 |
2003年 | 46198篇 |
2002年 | 42447篇 |
2001年 | 49095篇 |
2000年 | 50011篇 |
1999年 | 42331篇 |
1998年 | 13940篇 |
1997年 | 12421篇 |
1996年 | 12045篇 |
1995年 | 11518篇 |
1994年 | 10668篇 |
1993年 | 9987篇 |
1992年 | 33243篇 |
1991年 | 32451篇 |
1990年 | 31888篇 |
1989年 | 30663篇 |
1988年 | 27884篇 |
1987年 | 28006篇 |
1986年 | 26114篇 |
1985年 | 25310篇 |
1984年 | 19276篇 |
1983年 | 16299篇 |
1982年 | 10317篇 |
1981年 | 9266篇 |
1979年 | 17381篇 |
1978年 | 12744篇 |
1977年 | 10742篇 |
1976年 | 10208篇 |
1975年 | 10474篇 |
1974年 | 12635篇 |
1973年 | 12088篇 |
1972年 | 11039篇 |
1971年 | 10259篇 |
1970年 | 9510篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
921.
A W Biglan R Gonnering L B Lockhart B Rabin F H Fuerste 《American journal of ophthalmology》1986,101(2):232-235
To test the possibility of the formation of an antibody to botulinum A toxin after multiple injections of this potent neurotoxin, we collected serum samples from 28 patients who received 57 doses. These injections over a nine-month period with as much as 50 units per injection formed no detectable antibody. 相似文献
922.
923.
K Thomsen B J Riis J S Johansen C Christiansen P R?dbro 《Gynecological endocrinology》1987,1(2):169-175
Bone turnover before and after withdrawal of estrogen/gestagen treatment was studied in a randomized trial with 110 healthy female volunteers, who had passed a natural menopause 6 months to 3 years before the start of the study. Urinary excretion of intravenously injected 99m-technetium diphosphonate was measured as an index of bone turnover; plasma bone Gla protein and serum alkaline phosphatase were measured as indices of bone formation; and fasting urinary excretion of hydroxyproline and calcium were measured as estimates of bone resorption. During 2 years of hormone treatment, all variables decreased highly significantly (p less than 0.001) to a constant low level. Three months after withdrawal all variables increased highly significantly (p less than 0.001) towards, but not above, pretreatment and placebo levels. We conclude that withdrawal of estrogen/gestagen replacement therapy in postmenopausal women increases bone turnover, but not in excess of pretreatment values. This indicates that bone loss (after withdrawal) is similar to that seen in the placebo group and that a rebound phenomenon is unlikely. 相似文献
924.
925.
Andy Stergachis Catherine M Wetmore Michelle Pennylegion Randal D Beaton Bryant T Karras Dean Webb Diane Young Michael Loehr 《American journal of health-system pharmacy》2007,64(3):285-293
PURPOSE: The effectiveness of a point of dispensing (POD) used in a mass dispensing exercise was evaluated. METHODS: Public Health-Seattle & King County (PHSKC), in conjunction with the University of Washington, conducted a functional exercise of mass dispensing plans to test the effectiveness of a POD. Specifically, the organization and maintenance of patient flow, staffing model, signage, and dissemination of public information were evaluated. A data collection application using cellular telephones was used to record time and patient flow data to evaluate patient flow. Questionnaires distributed to staff and volunteer patients at the end of the exercise obtained feedback regarding the setup, organization, and operations of the POD. RESULTS: The POD was operational for approximately 68 minutes. The majority of POD staff reported feeling comfortable with their specific job tasks and duties within 15 minutes of opening the doors to the POD to the public. Staff questionnaires also revealed a high level of self-reported confidence in their ability and in the ability of their colleagues to perform the job-specific responsibilities required of them or respond to this hypothetical event. The majority of volunteer patients found the signs helpful and easy to follow and the check-in form easy to complete. Despite efforts to provide patients with oral and written information about the medications being dispensed, only 80% indicated that they knew how to take the medication, and only 73% reported understanding the medication instructions for all the individuals for whom they picked up medication. CONCLUSION: The majority of volunteer patients and staff who participated in a functional exercise of mass dispensing plans found the POD to be effective. Time-flow analysis provided preliminary estimates of the total amount of time needed to complete the dispensing process for each head of household. 相似文献
926.
927.
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. 总被引:11,自引:0,他引:11
Fairooz F Kabbinavar Joseph Schulz Michael McCleod Taral Patel John T Hamm J Randolph Hecht Robert Mass Brent Perrou Betty Nelson William F Novotny 《Journal of clinical oncology》2005,23(16):3697-3705
PURPOSE: Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, increases survival when combined with irinotecan-based chemotherapy in first-line treatment of metastatic colorectal cancer (CRC). This randomized, phase II trial compared bevacizumab plus fluorouracil and leucovorin (FU/LV) versus placebo plus FU/LV as first-line therapy in patients considered nonoptimal candidates for first-line irinotecan. PATIENTS AND METHODS: Patients had metastatic CRC and one of the following characteristics: age > or = 65 years, Eastern Cooperative Oncology Group performance status 1 or 2, serum albumin < or = 3.5 g/dL, or prior abdominal/pelvic radiotherapy. Patients were randomly assigned to FU/LV/placebo (n = 105) or FU/LV/bevacizumab (n = 104). The primary end point was overall survival. Secondary end points were progression-free survival, response rate, response duration, and quality of life. Safety was also assessed. RESULTS: Median survival was 16.6 months for the FU/LV/bevacizumab group and 12.9 months for the FU/LV/placebo group (hazard ratio, 0.79; P = .16). Median progression-free survival was 9.2 months (FU/LV/bevacizumab) and 5.5 months (FU/LV/placebo); hazard ratio was 0.50; P = .0002. Response rates were 26.0% (FU/LV/bevacizumab) and 15.2% (FU/LV/placebo) (P = .055); duration of response was 9.2 months (FU/LV/bevacizumab) and 6.8 months (FU/LV/placebo); hazard ratio was 0.42; P = .088. Grade 3 hypertension was more common with bevacizumab treatment (16% v 3%) but was controlled with oral medication and did not cause study drug discontinuation. CONCLUSION: Addition of bevacizumab to FU/LV as first-line therapy in CRC patients who were not considered optimal candidates for first-line irinotecan treatment provided clinically significant patient benefit, including statistically significant improvement in progression-free survival. 相似文献
928.
929.
AIMS: To assess the relationship between neighbourhood deprivation and the rate of gestational diabetes mellitus (GDM) using routinely collected data from a clinical information system, in Plymouth, UK. METHODS: Between 1 January 1996 and 31 December 1997, 3933 women residing within the Plymouth Primary Care Trust (PCT) were screened for GDM using indices of neighbourhood deprivation and prevalence of GDM. Areas (n = 43) were classified according to the Townsend index, measuring material deprivation. Pregnant women with and without GDM were compared. RESULTS: The prevalence of GDM was 1.7%[95%, confidence interval (CI) 1.20, 2.11]. The prevalence of GDM ranged from 1.05% (95% CI 0.60, 1.70) in the most deprived to 2.10% (95%, CI 1.34, 3.13), in the least deprived neighbourhood. Crude rates decreased by 50%[relative prevalence (RP) (95% CI) 0.50 (0.27, 0.94); P = 0.06] amongst those living in the most-deprived compared with those living in the least-deprived areas. Using a stepwise binary logistic regression model, older age at delivery significantly increased the risk of developing GDM. [RP (95%, CI) 1.09, (1.04, 1.13)]. Townsend deprivation score had no significant independent association with GDM when other covariates were considered. CONCLUSION: These data suggest that the neighbourhood context in which women live has no impact on the risk of GDM. Diabet. 相似文献
930.